Zinc and diabetic retinopathy

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Miao, Xiao ^a   Sun, Weixia ^b   Miao, Lining ^a   Fu, Yaowen ^b   Wang, Yonggang ^b   Su, Guanfang ^a   Liu, Quan ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; ZINC;

ANTIOXIDANT ACTIVITY; CATARACT; CHOROID; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMAN; LIPID PEROXIDATION; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETINA; REVIEW; SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 84879364896     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/425854     Document Type: Review

References (91)

1. Coleman J. E., Zinc Proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annual Review of Biochemistry 1992 61 897 946 2-s2.0-0026766977
2. Vallee B. L., Falchuk K. H., The biochemical basis of zinc physiology. Physiological Reviews 1993 73 1 79 118 2-s2.0-0027394031 (Pubitemid 23065434)
3. Cai L., Li X. K., Song Y., Cherian M. G., Essentiality, toxicology and chelation therapy of zinc and copper. Current Medicinal Chemistry 2005 12 23 2753 2763 2-s2.0-27744491186 10.2174/092986705774462950 (Pubitemid 41601572)
4. Palmiter R. D., Findley S. D., Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO Journal 1995 14 4 639 649 2-s2.0-0028948696
5. Gaither L. A., Eide D. J., The human zip1 transporter mediates zinc uptake in human k562 erythroleukemia cells. Journal of Biological Chemistry 2001 276 25 22258 22264 2-s2.0-0035933885 10.1074/jbc.M101772200
6. Kambe T., Yamaguchi-Iwai Y., Sasaki R., Nagao M., Overview of mammalian zinc transporters. Cellular and Molecular Life Sciences 2004 61 1 49 68 2-s2.0-1642580782 10.1007/s00018-003-3148-y (Pubitemid 38121899)
7. Palmiter R. D., Protection against zinc toxicity by metallothionein and zinc transporter 1. Proceedings of the National Academy of Sciences of the United States of America 2004 101 14 4918 4923 2-s2.0-1842636876 10.1073/pnas.0401022101 (Pubitemid 38469178)
8. Liuzzi J. P., Cousins R. J., Mammalian zinc transporters. Annual Review of Nutrition 2004 24 151 172 2-s2.0-3242741010 10.1146/annurev.nutr.24.012003. 132402 (Pubitemid 38949814)
9. Zhou Z., Sun X., James Kang Y., Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Experimental Biology and Medicine 2002 227 3 214 222 2-s2.0-0036521544
10. Cai L., Metallothionein as an adaptive protein prevents diabetes and its toxicity. Nonlinearity in Biology, Toxicology and Medicine 2004 2 89 103
11. Lefèbvre P., Diabetes yesterday, today and tomorrow. The action of the Internation Diabetes Federation. Revue Medicale de Liege 2005 60 5-6 273 277 2-s2.0-21744439962 (Pubitemid 40941492)
12. National Estimates and General Information on Diabetes and Prediabetes in the United States 2011 Atlanta, Ga, USA Centers for Disease Control and Prevention
13. Klein R., Klein B. E. K., Moss S. E., Cruickshanks K. J., The wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14- year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998 105 10 1801 1815 2-s2.0-0031793875 10.1016/S0161-6420(98)91020-X (Pubitemid 28509717)
14. Cheung N., Mitchell P., Wong T. Y., Diabetic retinopathy. The Lancet 2010 376 9735 124 136 2-s2.0-77955013602 10.1016/S0140-6736(09)62124-3
15. Powell S. R., The antioxidant properties of zinc. Journal of Nutrition 2000 130 1447S 1454S (Pubitemid 30244144)
16. Adachi Y., Yoshida J., Kodera Y., Kiss T., Jakusch T., Enyedy E. A., Yoshikawa Y., Sakurai H., Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochemical and Biophysical Research Communications 2006 351 1 165 170 2-s2.0-33750292900 10.1016/j.bbrc.2006.10.014 (Pubitemid 44635421)
17. Alscher D. M., Braun N., Biegger D., Stuelten C., Gawronski K., Mürdter T. E., Kuhlmann U., Fritz P., Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant. Kidney and Blood Pressure Research 2005 28 3 127 133 2-s2.0-22144455393 10.1159/000084921 (Pubitemid 40981168)
18. Baynes J. W., Thorpe S. R., Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999 48 1 1 9 2-s2.0-0032913309 10.2337/diabetes.48.1.1 (Pubitemid 29019345)
19. Piconi L., Quagliaro L., Ceriello A., Oxidative stress in diabetes. Clinical Chemistry and Laboratory Medicine 2003 41 9 1144 1149 2-s2.0-0142061586 10.1515/CCLM.2003.177 (Pubitemid 37265692)
20. Kowluru R. A., Tang J., Kern T. S., Abnormalities of retinal metabolism in diabetes and experimental galactosemia. Vii. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001 50 8 1938 1942 2-s2.0-0035434119 (Pubitemid 33641616)
21. Kowluru R. A., Kennedy A., Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opinion on Investigational Drugs 2001 10 9 1665 1676 2-s2.0-0034851575 10.1517/13543784.10.9.1665 (Pubitemid 32830146)
22. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005 54 6 1615 1625 2-s2.0-20044376702 10.2337/diabetes.54. 6.1615 (Pubitemid 40770750)
23. Bursell S. E., Clermont A. C., Aiello L. P., Aiello L. M., Schlossman D. K., Feener E. P., Laffel L., King G. L., High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999 22 8 1245 1251 2-s2.0-0032813888 10.2337/diacare.22.8.1245 (Pubitemid 29350231)
24. Nebbioso M., Federici M., Rusciano D., Evangelista M., Pescosolido N., Oxidative stress in preretinopathic diabetes subjects and antioxidants. Diabetes Technology and Therapeutics 2012 14 3 257 263 10.1089/dia.2011.0172
25. Millen A. E., Gruber M., Klein R., Klein B. E. K., Palta M., Mares J. A., Relations of serum ascorbic acid and α -tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 2003 158 3 225 233 2-s2.0-0042628148 10.1093/aje/kwg116 (Pubitemid 36944415)
26. Kanwar M., Chan P. S., Kern T. S., Kowluru R. A., Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Investigative Ophthalmology and Visual Science 2007 48 8 3805 3811 2-s2.0-34648825492 10.1167/iovs.06-1280 (Pubitemid 351261121)
27. Bray T. M., Bettger W. J., The physiological role of zinc as an antioxidant. Free Radical Biology and Medicine 1990 8 3 281 291 2-s2.0-0025239795 10.1016/0891-5849(90)90076-U (Pubitemid 20137051)
28. Jomova K., Valko M., Advances in metal-induced oxidative stress and human disease. Toxicology 2011 283 2-3 65 87 2-s2.0-79954642381 10.1016/j.tox.2011. 03.001
29. Prasad A. S., Zinc: role in immunity, oxidative stress and chronic inflammation. Current Opinion in Clinical Nutrition and Metabolic Care 2009 12 6 646 652 10.1097/MCO.0b013e3283312956
30. Prasad A. S., Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Experimental Gerontology 2008 43 5 370 377 2-s2.0-42149155984 10.1016/j.exger.2007.10.013 (Pubitemid 351540838)
31. Walter R. M., Uriu-Hare J. Y., Olin K. L., Oster M. H., Anawalt B. D., Critchfield J. W., Keen C. L., Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991 14 11 1050 1056 2-s2.0-0025936532
32. Moustafa S. A., Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicology and Applied Pharmacology 2004 201 2 149 155 2-s2.0-8444241857 10.1016/j.taap.2004.05.014 (Pubitemid 39487162)
33. Roussel A. M., Kerkeni A., Zouari N., Mahjoub S., Matheau J. M., Anderson R. A., Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. Journal of the American College of Nutrition 2003 22 4 316 321 2-s2.0-0043270334 (Pubitemid 36927768)
34. Calesnick B. D. A., Zinc deficiency and zinc toxicity. American Family Physician 1988 37 267 270
35. Ugarte M., Grime G. W., Lord G., Geraki K., Collingwood J. F., Finnegan M. E., Farnfield H., Merchant M., Bailey M. J., Ward N. I., Foster P. J., Bishop P. N., Osborne N. N., Concentration of various trace elements in the rat retina and their distribution in different structures. Metallomics 2012 4 1245 1254
36. Rogers J. M., Hurley L. S., Effects of zinc deficiency on morphogenesis of the fetal rat eye. Development 1987 99 2 231 238 2-s2.0-0023139773 (Pubitemid 17047603)
37. Grahn B. H., Paterson P. G., Gottschall-Pass K. T., Zhang Z., Zinc and the eye. Journal of the American College of Nutrition 2001 20 2 106 118 2-s2.0-0035022273 (Pubitemid 32423600)
38. Muga S. J., Grider A., Partial characterization of a human zinc-deficiency syndrome by differential display. Biological Trace Element Research 1999 68 1 1 12 2-s2.0-0032918036 (Pubitemid 29177686)
39. Pati S. K., Mukherji R., Serum zinc in corneal ulcer-a preliminary report. Indian Journal of Ophthalmology 1991 39 3 134 135 2-s2.0-0026183074
40. Berman M. B., Manabe R., Corneal collagenases: evidence for zinc metalloenzymes. Annals of Ophthalmology 1973 5 11 1193 1209 2-s2.0-0015755892
41. Morrison S. A., Russell R. M., Carney E. A., Oaks E. V., Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. American Journal of Clinical Nutrition 1978 31 2 276 281 2-s2.0-0017797249 (Pubitemid 8302210)
42. Afridi H. I., Kazi T. G., Kazi N., Kandhro G. A., Baig J. A., Shah A. Q., Wadhwa S. K., Khan S., Kolachi N. F., Shah F., Jamali M. K., Arain M. B., Sirajuddin, Evaluation of status of zinc, copper, and iron levels in biological samples of normal children and children with night blindness with age groups of 3-7 and 8-12 years. Biological Trace Element Research 2011 142 323 334
43. Mochizuki K., Murase H., Imose M., Kawakami H., Sawada A., Improvement of scotopic electroretinograms and night blindness with recovery of serum zinc levels. Japanese Journal of Ophthalmology 2006 50 6 532 536 2-s2.0-33845721376 10.1007/s10384-006-0376-3 (Pubitemid 44974224)
44. Huber A. M., Gershoff S. N., Effects of zinc deficiency on the oxidation of retinol and ethanol in rats. Journal of Nutrition 1975 105 11 1486 1490 2-s2.0-0016793950
45. Bok D., Retinal photoreceptor-pigment epithelium interactions. Investigative Ophthalmology and Visual Science 1985 26 12 1659 1694 2-s2.0-0022344155 (Pubitemid 16172107)
46. Redenti S., Ripps H., Chappell R. L., Zinc release at the synaptic terminals of rod photoreceptors. Experimental Eye Research 2007 85 4 580 584 2-s2.0-35148886412 10.1016/j.exer.2007.07.017 (Pubitemid 47542267)
47. Jeru I., The role of zinc in the appearance of cataract. Oftalmologia 1997 41 4 329 332 2-s2.0-0030631541
48. Kassoff A., Kassoff J., Buehler J., Eglow M., Kaufman F., Mehu M., Kieval S., Mairs M., A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins c and e and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Archives of Ophthalmology 2001 119 10 1439 1452 (Pubitemid 32963247)
49. Sato M., Bremner I., Oxygen free radicals and metallothionein. Free Radical Biology and Medicine 1993 14 3 325 337 2-s2.0-0027533507 10.1016/0891-5849(93)90029-T (Pubitemid 23066373)
50. Tsuruma K., Shimazaki H., Ohno Y., Inoue Y., Honda A., Imai S., Lee J., Shimazawa M., Satoh M., Hara H., Metallothionein-iii deficiency exacerbates light-induced retinal degeneration. Investigative Ophthalmology & Visual Science 2012 53 7896 7903
51. Erie J. C., Good J. A., Butz J. A., Pulido J. S., Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration. American Journal of Ophthalmology 2009 147 2 276 282 2-s2.0-58249104078 10.1016/j.ajo.2008.08.014
52. Organisciak D., Wong P., Rapp C., Ziesel A., Rangarajan R., Lang J., Light-induced retinal degeneration is prevented by zinc, a component in the age-related eye disease study formulation. Photochemistry and Photobiology 2012 88 6 1396 1407 10.1111/j.1751-1097.2012.01134.x
53. Tate D. J., Newsome D. A., Oliver P. D., Metallothionein shows an age-related decrease in human macular retinal pigment epithelium. Investigative Ophthalmology and Visual Science 1993 34 7 2348 2351 2-s2.0-0027264819 (Pubitemid 23191265)
54. Nicolas M. G., Fujiki K., Murayama K., Suzuki M. T., Shindo N., Hotta Y., Iwata F., Fujimura T., Yoshikawa Y., Cho F., Kanai A., Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys. II. Suppression of metallothionein synthesis in the retina in oxidative stress. Experimental Eye Research 1996 62 4 399 408 2-s2.0-0029936705 10.1006/exer.1996.0045 (Pubitemid 26150373)
55. Sasaki M., Shinoda H., Koto T., Uchida A., Tsubota K., Ozawa Y., Use of micronutrient supplement for preventing advanced age-related macular degeneration in Japan. Archives of Ophthalmology 2012 130 2 254 255 10.1001/archopthalmol.2011.1368
56. Olson J. H., Erie J. C., Bakri S. J., Nutritional supplementation and age-related macular degeneration. Seminars in Ophthalmology 2011 26 3 131 136 2-s2.0-79957585321 10.3109/08820538.2011.577131
57. Hasan N. A., Effects of trace elements on albumin and lipoprotein glycation in diabetic retinopathy. Saudi Medical Journal 2009 30 10 1263 1271 2-s2.0-70449640747
58. Rudolf E., Peychl J., Radocha J., Cervinka M., Zinc and its role in the regulation of cell death. Ceskoslovenska Fysiologie 2001 50 4 201 210 2-s2.0-0038256553
59. Hanna P. M., Kadiiska M. B., Jordan S. J., Mason R. P., Role of metallothionein in zinc(II) and chromium(III) mediated tolerance to carbon tetrachloride hepatotoxicity: evidence against a trichloromethyl radical-scavenging mechanism. Chemical Research in Toxicology 1993 6 5 711 717 2-s2.0-0027495373 (Pubitemid 23290025)
60. 4 ratio in allyl alcohol-treated male rats and possible protection with zinc. International Journal of Toxicology 2001 20 1 15 20 2-s2.0-0035112463 10.1080/109158101750103332 (Pubitemid 32179911)
61. 2+-induced apoptosis in cancer cells. Free Radical Biology and Medicine 2002 32 5 431 445 2-s2.0-0036489216 10.1016/S0891-5849(01)00830-9 (Pubitemid 34182834)
62. Evans J. R., Antioxidant vitamin and mineral supplements for age-related macular degeneration. Cochrane Database of Systematic Reviews 2002 1 CD000254 2-s2.0-0036358315
63. Duzguner V., Kaya S., Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Free Radical Biology and Medicine 2007 42 10 1481 1486 2-s2.0-34247130390 10.1016/j.freeradbiomed.2007.02.021 (Pubitemid 46590618)
64. Puig S., Thiele D. J., Molecular mechanisms of copper uptake and distribution. Current Opinion in Chemical Biology 2002 6 2 171 180 2-s2.0-0036525717 10.1016/S1367-5931(02)00298-3 (Pubitemid 34251372)
65. Uriu-Adams J. Y., Keen C. L., Copper, oxidative stress, and human health. Molecular Aspects of Medicine 2005 26 4-5 268 298 2-s2.0-24044481966 10.1016/j.mam.2005.07.015 (Pubitemid 41225353)
66. Ansari N. H., Zhang W., Fulep E., Mansour A., Prevention of pericyte loss by trolox in diabetic rat retina. Journal of Toxicology and Environmental Health A 1998 54 6 467 475 2-s2.0-0032563080 (Pubitemid 28532444)
67. Kowluru R. A., Engerman R. L., Case G. L., Kern T. S., Retinal glutamate in diabetes and effect of antioxidants. Neurochemistry International 2001 38 5 385 390 2-s2.0-0035104682 10.1016/S0197-0186(00)00112-1 (Pubitemid 32166895)
68. Obrosova I. G., Minchenko A. G., Marinescu V., Fathallah L., Kennedy A., Stockert C. M., Frank R. N., Stevens M. J., Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin- diabetic rats. Diabetologia 2001 44 9 1102 1110 2-s2.0-0034846788 10.1007/s001250100631 (Pubitemid 32835501)
69. Agardh C. D., Agardh E., Hultberg B., Qian Y., Östenson C. G., The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. Current Eye Research 1998 17 3 251 256 2-s2.0-0031907365 10.1076/ceyr.17.3.251.5217 (Pubitemid 28138272)
70. Kowluru R. A., Engerman R. L., Kern T. S., Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Current Eye Research 2000 21 4 814 819 2-s2.0-0034493893 10.1076/ceyr.21.4.814.5545 (Pubitemid 32099432)
71. Woollard A. C. S., Bascal Z. A., Armstrong G. R., Wolff S. P., Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes 1990 39 11 1347 1352 2-s2.0-0025155536 (Pubitemid 20372222)
72. Moustafa S. A., Effect of glutathione depletion on carbohydrate metabolism in the rat. Research Communications in Pharmacology and Toxicology 1998 3 1-2 55 64 (Pubitemid 28429273)
73. Fink R. I., Huecksteadt T., Karaoghlanian Z., The effects of aging on glucose metabolism in adipocytes from Fischer rats. Endocrinology 1986 118 3 1139 1147 2-s2.0-0022547877 (Pubitemid 16080150)
74. Moustafa S. A., Webster J. E., Mattar F. E., Effects of aging and antioxidants on glucose transport in rat adipocytes. Gerontology 1995 41 6 301 307 2-s2.0-0028845956
75. Kowald A., Kirkwood T. B. L., Towards a new theory of aging and the protein error theory. Journal of Theoretical Biology 1994 168 75 94
76. Thomas J. P., Bachowski G. J., Girotti A. W., Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochimica et Biophysica Acta 1986 884 3 448 461 2-s2.0-0022908892 (Pubitemid 17010667)
77. Suntres Z. E., Lui E. M. K., Biochemical mechanism of metallothionein-carbon tetrachloride interaction in vitro. Biochemical Pharmacology 1990 39 5 833 840 2-s2.0-0025141330 10.1016/0006-2952(90)90197-S (Pubitemid 20060678)
78. Thornalley P. J., Vasak M., Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochimica et Biophysica Acta 1985 827 1 36 44 2-s2.0-0021944046 10.1016/0167-4838(85)90098-6 (Pubitemid 15125549)
79. St Croix C. M., Wasserloos K. J., Dineley K. E., Reynolds I. J., Levitan E. S., Pitt B. R., Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. American Journal of Physiology 2002 282 2 L185 L192 2-s2.0-0036088001 (Pubitemid 34654669)
80. Zhang Y., Zhao W., Zhang H. J., Domann F. E., Oberley L. W., Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Research 2002 62 4 1205 1212 2-s2.0-0036170568 (Pubitemid 34160310)
81. Yamagishi S. I., Amano S., Inagaki Y., Okamoto T., Koga K., Sasaki N., Yamamoto H., Takeuchi M., Makita Z., Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochemical and Biophysical Research Communications 2002 290 3 973 978 2-s2.0-0036289323 10.1006/bbrc.2001.6312 (Pubitemid 34687457)
82. Kim J., Kim K. M., Kim C.-S., Sohn E., Lee Y. M., Jo K., Kim J. S., Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radical Biology and Medicine 2012 53 2 357 365 10.1016/j. freeradbiomed.2012.04.030
83. Clermont A. C., Aiello L. P., Mori F., Aiello L. M., Bursell S. E., Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. American Journal of Ophthalmology 1997 124 4 433 446 2-s2.0-0030770396 (Pubitemid 27425869)
84. Wang X., Wang G., Wang Y., Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. American Journal of Ophthalmology 2009 148 6 883 889 2-s2.0-70449622732 10.1016/j.ajo.2009.07.007
85. Adamis A. P., Miller J. W., Bernal M. T., D'Amico D. J., Folkman J., Yeo-T. K., Yeo K. T., Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. American Journal of Ophthalmology 1994 118 4 445 450 2-s2.0-0028123090 (Pubitemid 24307211)
86. Andreoli C. M., Miller J. W., Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Current Opinion in Ophthalmology 2007 18 6 502 508 2-s2.0-38449100932 10.1097/ICU.0b013e3282f0ca54 (Pubitemid 351339405)
87. Uzzo R. G., Crispen P. L., Golovine K., Makhov P., Horwitz E. M., Kolenko V. M., Diverse effects of zinc on NF- B and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis 2006 27 10 1980 1990 2-s2.0-33745493746 10.1093/carcin/bgl034 (Pubitemid 44530572)
88. DeNiro M., Al-Mohanna F. A., Zinc transporter 8 (znt8) expression is reduced by ischemic insults: a potential therapeutic target to prevent ischemic retinopathy. PLoS ONE 2012 7 11 e50360 10.1371/journal.pone.0050360
89. Adachi T., Teramachi M., Yasuda H., Kamiya T., Hara H., Contribution of p38 MAPK, NF- B and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Archives of Biochemistry and Biophysics 2012 520 1 30 35 10.1016/j.abb.2012.01.014
90. Zhao Y., Tan Y., Dai J., Li B., Guo L., Cui J., Wang G., Shi X., Zhang X., Mellen N., Li W., Cai L., Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in mice. Toxicology Letters 2011 200 1-2 100 106 2-s2.0-78650177805 10.1016/j.toxlet.2010.11.001
91. Scheppke L., Aguilar E., Gariano R. F., Jacobson R., Hood J., Doukas J., Cao J., Noronha G., Yee S., Weis S., Martin M. B., Soll R., Cheresh D. A., Friedlander M., Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. Journal of Clinical Investigation 2008 118 6 2337 2346 2-s2.0-45749143528 10.1172/JCI33361 (Pubitemid 351872350)